A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2017;67:7–30.
   PubMed Web of Science ®Google Scholar
• Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100:672–9.
   Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013;13:714–26.
   PubMed Web of Science ®Google Scholar
• Kachalaki S, Ebrahimi M, Mohamed Khosroshahi L, et al. Cancer chemoresistance; biochemical and molecular aspects: a brief overview. Eur J Pharm Sci 2016;89:20–30.
   PubMed Web of Science ®Google Scholar
• Allardyce CS, Dyson PJ. Metal-based drugs that break the rules. Dalton Trans 2016;45:3201–209.
   PubMed Web of Science ®Google Scholar
• Dilruba S, Kalayda GV. Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol 2016;77:1103–24.
   PubMed Web of Science ®Google Scholar
• Bielawski K, Czarnomysy R, Muszyńska A, et al. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes. Environ Toxicol Pharmacol 2013;35:254–64.
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Bielawska A, Muszyńska A, Bielawski K. Effects of novel alkyl pyridine platinum complexes on apoptosis in Ishikawa endometrial cancer cells. Med Chem 2015;11:540–50.
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Bielawski K, Muszyńska A, et al. Biological evaluation of dimethylpyridine-platinum complexes with potent antiproliferative activity. J Enzyme Inhib Med Chem 2016;31:150–65.
   PubMed Web of Science ®Google Scholar
• Popławska B, Bielawska A, Surazyński A, et al. Novel dinuclear platinum(II) complexes targets NFκB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells. Folia Histochem Cytobiol 2009;47:141–6.
   Web of Science ®Google Scholar
• Zerzankova L, Kostrhunova H, Vojtiskova M, et al. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers. Biochem Pharmacol 2010;80:344–51.
   PubMed Web of Science ®Google Scholar
• Bielawska K, Popławska A, Surazyński B, Czarnomysy AR. The effect of a novel dinuclear platinum complex with berenil and 2-picoline ligands on growth of human breast cancer cells. Acta Pol Pharm 2010;67:609–14.
   PubMed Web of Science ®Google Scholar
• Czarnomysy R, Surażyński A, Popławska B, et al. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells. Mol Cell Biochem 2017;427:13–22.
   PubMed Web of Science ®Google Scholar
• Gornowicz A, Bielawska A, Czarnomysy R, et al. The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells. Mol Cell Biochem 2015;408:103–13.
   PubMed Web of Science ®Google Scholar
• Ribeiro N, Roy S, Butenko N, et al. New Cu(II) complexes with pyrazolyl derived Schiff base ligands: synthesis and biological evaluation. J Inorg Biochem 2017;174:63–75.
   PubMed Web of Science ®Google Scholar
• Thota S, Vallala S, Yerra R, et al. Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru(II) complexes. Int J Biol Macromol 2016;82:663–70.
   PubMed Web of Science ®Google Scholar
• Quirante J, Ruiz D, Gonzalez A, et al. Platinum(II) and palladium(II) complexes with (N, N′) and (C, N, N′)- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities. J Inorg Biochem 2011;105:1720–8.
   PubMed Web of Science ®Google Scholar
• Ismail NSM, Ali GME, Ibrahim DA, Elmetwali AM. Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. Fut J Pharm Sci 2016;2:60–70.
   Web of Science ®Google Scholar
• Abadi AH, Eissa AA, Hassan GS. Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem Pharm Bull 2003;51:838–44.
   PubMed Web of Science ®Google Scholar
• Atamanyuk D, Zimenkovsky B, Lesyk R. Synthesis and anticancer activity of novel thiopyrano[2,3-d]thiazole-based compounds containing norbornane moiety. J Sulfur Chem 2008;29:151–62.
   Web of Science ®Google Scholar
• Blanc C, Deveraux Q, Krajewski LS. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res 2000;60:4386–90.
   PubMed Web of Science ®Google Scholar
• Farrel N. Metal complex as drugs and chematheraoeutic agents. In: Comprehensive coordination chemistry, vol. 9. 2nd ed. Amsterdam: Elsevier Ltd; 2003:809–40.
   Google Scholar
• Lazarević T, Rilak A, Bugarčić ŽD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem 2017;142:8–31.
   PubMed Web of Science ®Google Scholar
• Li YS, Peng B, Ma L, et al. Synthesis, crystal structures and antitumor activity of two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one. Eur J Med Chem 2017;127:137–46.
   PubMed Web of Science ®Google Scholar
• Fahmy HH, Khalifa NM, Ismail MM, et al. Biological validation of novel polysubstituted pyrazole candidates with in vitro anticancer activities. Molecules 2016;21:271.
   PubMed Web of Science ®Google Scholar
• Keter FK, Kanyanda S, Lyantagaye SS, et al. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents. Cancer Chemother Pharmacol 2008;63:127–38.
   PubMed Web of Science ®Google Scholar
• Sakai K, Tomitab Y, Ueb T, et al. Syntheses, antitumor activity, and molecular mechanics studies of cis-PtCl2(pzH)2 (pzH = pyrazole) and related complexes. Crystal structure of a novel Magnus-type double-salt [Pt(pzH)4][PtCl4][cis-PtCl2(pzH)2]2 involving two perpendicularly aligned 1D chains. Inorganica Chimica Acta 2000;297:64–71.
   Web of Science ®Google Scholar
• Ciesielska E, Szulawska A, Studzian K, et al. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyrazole ligands. J Inorg Biochem 2006;100:1579–85.
   PubMed Web of Science ®Google Scholar
• Li S, Xu S, Tang Y, et al. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives. Bioorg Med Chem Lett 2014;24:586–90.
   PubMed Web of Science ®Google Scholar
• Sun L, Bera H, Chui WK. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase. Eur J Med Chem 2013;65:1–11.
   PubMed Web of Science ®Google Scholar
• Gümüş F, Algül O, Eren G, et al. Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum(II) complexes with 2-substituted benzimidazole ligands. Eur J Med Chem 2003;38:473–80.
   PubMed Web of Science ®Google Scholar
• Chan KT, Meng FY, Li Q, et al. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 2010;294:118–24.
   PubMed Web of Science ®Google Scholar
• Blank M, Shiloh Y. Programs for cell death: apoptosis is only one way to go. Cell Cycle 2007;6:686–95.
   PubMed Web of Science ®Google Scholar
• Qin YJ, Li YJ, Jiang AQ, et al. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Eur J Med Chem 2015;94:47–57.
   Web of Science ®Google Scholar
• Kamal A, Shaik AB, Polepalli S, et al. Pyrazole-oxadiazole conjugates: synthesis, antiproliferative activity and inhibition of tubulin polymerization. Org Biomol Chem 2014;12:7993–8007.
   PubMed Web of Science ®Google Scholar
• Velma V, Dasari SR, Tchounwou PB. Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomarker Insights 2016;11:113–21.
   PubMed Web of Science ®Google Scholar
• Kumar NP, Sharma P, Kumari SS, et al. Synthesis of substituted phenanthrene-9-benzimidazole conjugates: cytotoxicity evaluation and apoptosis inducing studies. Eur J Med Chem 2017;140:128–40.
   PubMed Web of Science ®Google Scholar
• Wang H, Zheng J, Xu W, et al. A new series of cytotoxic pyrazoline derivatives as potential anticancer agents that induce cell cycle arrest and apoptosis. Molecules 2017;22:10.
   Web of Science ®Google Scholar
• Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999;39:295–312.
   PubMed Web of Science ®Google Scholar
• Shoshan-Barmatz V, Krelin Y, Chen Q. VDAC1 as a player in mitochondria-mediated apoptosis and target for modulating apoptosis. Curr Med Chem 2017;24:4435–46.
   PubMed Web of Science ®Google Scholar
• Krętowski R, Borzym-Kluczyk M, Stypułkowska A, et al. Low glucose dependent decrease of apoptosis and induction of autophagy in breast cancer MCF-7 cells. Mol Cell Biochem 2016;417:35–47.
   PubMed Web of Science ®Google Scholar
• Pinato O, Musetti C, Farrell NP, Sissi C. Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation. J Inorg Biochem 2013;122:27–37.
   PubMed Web of Science ®Google Scholar
• Collins I, Workman P. New approaches to molecular cancer therapeutics. Nat Chem Biol 2006;2:689–700.
   PubMed Web of Science ®Google Scholar
• Faria JV, Vegi PF, Miguita AGC, et al. Recently reported biological activities of pyrazole compounds. Bioorg Med Chem 2017;25:5891–903.
   PubMed Web of Science ®Google Scholar